New Centre of Excellence Focused on Solutions for Environmental Health, Food Safety and Drug Discovery SINGAPORE - PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today celebrated the opening of a new Centre of Excellence in Singapore. The PerkinElmer Inc. Centre of Excellence in Singapore will serve as a base for the Company's R&D efforts in Asia, and will focus on the development of new precision instrumentation and chemistries for a range of scientific and industrial laboratory applications, including drug discovery and development, environmental monitoring, food safety, and sustainable energy. "The opening of the PerkinElmer Inc. Centre of Excellence in Singapore builds on our efforts to make significant and long-term investments in Asia-Pacific to support the expansion of the health and environmental infrastructures of nations throughout the region," said Dr. Daniel R. Marshak, vice president and chief scientific officer, PerkinElmer, Inc. "This investment will enable us to leverage in-country expertise and resources to drive the development of new, innovative solutions to meet the changing needs of our local and global customers." "We are pleased that PerkinElmer is expanding its R&D base in Singapore," said Ms. Aw Kah Peng, assistant managing director, Singapore Economic Development Board. "The investment is timely and much welcomed by the scientific community in Singapore. The R&D centre provides a platform for PerkinElmer to work with public research centers and global biopharmaceutical companies to develop and innovate new tools and applications to support the biomedical sciences research in Singapore." The new Centre of Excellence, led by Anthony Fernando, will manufacture instruments for atomic absorption spectroscopy and UV/Visible spectroscopy to detect both inorganic and organic materials in the environment, food, materials and oil industries. The new facility will also focus R&D efforts in support of the expansion of PerkinElmer's EcoAnalytix? solutions family. EcoAnalytix is PerkinElmer's revolutionary problem-solving initiative that addresses the global imperatives of food and consumer product safety, water quality and sustainable energy development. "PerkinElmer is committed to delivering world-class analytical measurement systems to help research and testing laboratories across the globe drive productivity, accuracy and quality. The appointment of Anthony Fernando as the R&D Centre of Excellence Leader, Asia provides us with the ideal resource to further strengthen our position as we accomplish these goals," said Dr. Richard Begley, president, Analytical Sciences, PerkinElmer, Inc. "The products that will be researched and developed here in Singapore will impact every aspect of our lives, from systems to test the safety of the water we drink and the quality of the air we breathe, to technology that may help to identify a new medication to cure a disease." Asia represents a key growth region for PerkinElmer, with significant growth opportunities in areas such as pharmaceutical research, neonatal and prenatal screening, and environmental monitoring. Factors Affecting Future Performance This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow, revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as "believes," "intends," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) our failure to introduce new products in a timely manner; (2) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (3) our failure to protect adequately our intellectual property; (4) the loss of any of our licenses or licensed rights; (5) our ability to compete effectively; (6) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (7) our ability to produce an adequate quantity of products to meet our customers' demands; (8) our failure to maintain compliance with applicable government regulations; (9) regulatory changes; (10) our failure to comply with health care industry regulations; (11) economic, political and other risks associated with foreign operations; (12) our ability to retain key personnel; (13) restrictions in our credit agreements; (14) our ability to realize the full value of our intangible assets; and (15) other factors which we describe under the caption "Risk Factors" in our most recent annual report on Form 10-K and in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release. PerkinElmer, Inc. is a global technology leader driving growth and innovation in Health Sciences and Photonics markets to improve the quality of life. The Company reported revenues of $1.8 billion in 2007, has 9,100 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE. For further information regarding PerkinElmer, please contact: Investor Relations: Michael A. Lawless PerkinElmer, Inc. (781) 663-5659 Media Contact: Jin Kien EASTWEST Public Relations (+65 9321 6122) Michael Drury EASTWEST Public Relations (+65 8186 8091)